| 1 | Association between alcohol consumption and peripheral artery disease: two de novo prospective cohorts and a systematic review with meta-analysis | 2.0 | 15 | Citations (PDF) |
| 2 | Concerns about instrumental variable selection for biological effect versus uptake of proton pump inhibitors in Mendelian randomisation analysis | 16.8 | 6 | Citations (PDF) |
| 3 | Modifiable risk factors and inflammation-related proteins in polymyalgia rheumatica: genome-wide meta-analysis and Mendelian randomization | 1.9 | 4 | Citations (PDF) |
| 4 | Sex differences in risk factor relationships with subarachnoid haemorrhage and intracranial aneurysms: A Mendelian randomization study | 3.8 | 2 | Citations (PDF) |
| 5 | Human Genetic Evidence to Inform Clinical Development of IL-6 Signaling Inhibition for Abdominal Aortic Aneurysm | 6.0 | 4 | Citations (PDF) |
| 6 | Optimizing treatment of cardiovascular risk factors in cerebral small vessel disease using geneticsBrain, 2025, 148, 1936-1949 | 8.4 | 8 | Citations (PDF) |
| 7 | Proteins Involved in Endothelial Function and Inflammation Are Implicated in Cerebral Small Vessel Disease | 5.9 | 10 | Citations (PDF) |
| 8 | Evaluating the Cardiometabolic Efficacy and Safety of Lipoprotein Lipase Pathway Targets in Combination With Approved Lipid-Lowering Targets: A Drug Target Mendelian Randomization Study | 2.9 | 6 | Citations (PDF) |
| 9 | Factorial Mendelian randomization of lipoprotein (a) lowering, low-density lipoprotein cholesterol lowering, and lifestyle improvements: joint associations with cardiovascular risk | 4.9 | 7 | Citations (PDF) |
| 10 | Circulating Blood-Based Proteins in Psychopathology and Cognition | 12.4 | 9 | Citations (PDF) |
| 11 | Challenges in interpreting Mendelian randomization studies with a disease as the exposure: Using COVID-19 liability studies as an exemplar | 3.0 | 7 | Citations (PDF) |
| 12 | The role of estimation in Mendelian randomization: should Mendelian randomization investigations provide estimates? 2025, 1, | | 7 | Citations (PDF) |
| 13 | Search for common genetic variants to allow reliable Mendelian randomization investigations into ketone metabolism | 5.3 | 3 | Citations (PDF) |
| 14 | Reassessing the validity of using weighted linear models to implement multi-generational GWAS-by-subtraction: a response to Evans et al. | 1.5 | 0 | Citations (PDF) |
| 15 | Cerebrospinal fluid haptoglobin levels and outcome after aneurysmal subarachnoid haemorrhage: Evidence from Mendelian randomization | 2.3 | 0 | Citations (PDF) |
| 16 | Proteome‐Wide Mendelian Randomization Identifies Natriuretic Peptide‐B and Novel Proteins as Potential Regulators of Pulse Pressure in Humans | 4.0 | 1 | Citations (PDF) |
| 17 | Genetically Predicted Expression of Autophagy-Related Genes and Thoracic Aortic Aging: A Mendelian Randomization Study | 6.6 | 0 | Citations (PDF) |
| 18 | Vitamin D is associated with reduced risk of Sjögren’s syndrome: a Mendelian randomization study | 1.9 | 8 | Citations (PDF) |
| 19 | Birth weight influences cardiac structure, function, and disease risk: evidence of a causal association | 2.2 | 46 | Citations (PDF) |
| 20 | Inconsistency in UK Biobank Event Definitions From Different Data Sources and Its Impact on Bias and Generalizability: A Case Study of Venous Thromboembolism | 3.3 | 9 | Citations (PDF) |
| 21 | Plasma adiponectin levels and risk of heart failure, atrial fibrillation, aortic valve stenosis, and myocardial infarction: large-scale observational and Mendelian randomization evidence | 5.5 | 23 | Citations (PDF) |
| 22 | Impaired glucose tolerance and cardiovascular risk factors in relation to infertility: a Mendelian randomization analysis in the Norwegian Mother, Father, and Child Cohort Study | 1.0 | 7 | Citations (PDF) |
| 23 | Mendelian Randomization as a Tool for Cardiovascular Research | 11.1 | 114 | Citations (PDF) |
| 24 | Hypertensive disorders of pregnancy and cardiovascular disease risk: a Mendelian randomisation studyHeart, 2024, 110, 710-717 | 3.9 | 15 | Citations (PDF) |
| 25 | Mediating Factors in the Association of Maternal Educational Level With Pregnancy Outcomes | 6.6 | 57 | Citations (PDF) |
| 26 | A Bayesian approach to Mendelian randomization using summary statistics in the univariable and multivariable settings with correlated pleiotropy | 6.5 | 39 | Citations (PDF) |
| 27 | Lipoprotein(a) Is Markedly More Atherogenic Than LDL | 2.3 | 216 | Citations (PDF) |
| 28 | Dose-Response Associations of Lipid Traits With Coronary Artery Disease and Mortality | 6.6 | 21 | Citations (PDF) |
| 29 | Incorporating biological and clinical insights into variant choice for Mendelian randomisation: examples and principles | 2.6 | 47 | Citations (PDF) |
| 30 | Mendelian Randomization Applied to Neurology | 1.0 | 44 | Citations (PDF) |
| 31 | Proteomic Associations of NT-proBNP (N-Terminal Pro-B-Type Natriuretic Peptide) in Heart Failure With Preserved Ejection Fraction | 4.4 | 24 | Citations (PDF) |
| 32 | A data-adaptive method for investigating effect heterogeneity with high-dimensional covariates in Mendelian randomization | 2.5 | 7 | Citations (PDF) |
| 33 | Robust use of phenotypic heterogeneity at drug target genes for mechanistic insights: Application of cis‐multivariable Mendelian randomization to GLP1R gene region | 3.1 | 25 | Citations (PDF) |
| 34 | Multi-biobank summary data Mendelian randomisation does not support a causal effect of IL-6 signalling on risk of pulmonary arterial hypertension | 8.7 | 5 | Citations (PDF) |
| 35 | Alcohol consumption and the risk of all-cause and cause-specific mortality—a linear and nonlinear Mendelian randomization study | 4.9 | 28 | Citations (PDF) |
| 36 | LDL-c Lowering, Ischemic Stroke, and Small Vessel Disease Brain Imaging Biomarkers: A Mendelian Randomization Study | 5.9 | 7 | Citations (PDF) |
| 37 | Selecting invalid instruments to improve Mendelian randomization with two-sample summary data | 1.2 | 4 | Citations (PDF) |
| 38 | ASSOCIATIONS OF GENETICALLY PREDICTED LOW DENSITY LIPOPROTEIN CHOLESTEROL-LOWERING DRUG INHIBITION WITH AORTIC STRUCTURE AND FUNCTION: A DRUG-TARGET MENDELIAN RANDOMIZATION STUDY | 2.3 | 0 | Citations (PDF) |
| 39 | MVMRmode: Introducing an R package for plurality valid estimators for multivariable Mendelian randomisation | 2.3 | 2 | Citations (PDF) |
| 40 | Risk Factors for Intracerebral Hemorrhage: Genome-Wide Association Study and Mendelian Randomization Analyses | 5.9 | 29 | Citations (PDF) |
| 41 | Cardiovascular disease risk factors and infertility: multivariable analyses and one-sample Mendelian randomization analyses in the Trøndelag Health Study | 7.6 | 4 | Citations (PDF) |
| 42 | Genetic predictors of traits in elderly subjects: risk of survival bias and reverse causation | 2.2 | 6 | Citations (PDF) |
| 43 | Towards more reliable non-linear mendelian randomization investigations | 5.3 | 18 | Citations (PDF) |
| 44 | Body mass index and all-cause mortality in HUNT and UK biobank studies: revised non-linear Mendelian randomisation analyses | 1.9 | 14 | Citations (PDF) |
| 45 | Glucagon‐Like Peptide‐1 Receptor Agonism and Suicide Risk: Evidence From Mendelian Randomization | 4.0 | 7 | Citations (PDF) |
| 46 | Comparison of caffeine consumption behavior with plasma caffeine levels as exposure measures in drug-target mendelian randomization | 3.3 | 9 | Citations (PDF) |
| 47 | Vitamin D, chronic pain, and depression: linear and non-linear Mendelian randomization analyses | 5.2 | 8 | Citations (PDF) |
| 48 | Use of Mendelian randomization to assess the causal status of modifiable exposures for rheumatic diseases | 3.9 | 9 | Citations (PDF) |
| 49 | Multi-biobank Mendelian randomization analyses identify opposing pathways in plasma low-density lipoprotein-cholesterol lowering and gallstone disease | 5.3 | 14 | Citations (PDF) |
| 50 | Independent Effects of Blood Pressure on Intraocular Pressure and Retinal Ganglion Cell Degeneration: A Mendelian Randomization Study 2024, 65, 35 | | 5 | Citations (PDF) |
| 51 | Proteome- and Transcriptome-Wide Genetic Analysis Identifies Biological Pathways and Candidate Drug Targets for Preeclampsia | 2.9 | 10 | Citations (PDF) |
| 52 | Childhood-onset type 1 diabetes and subsequent adult psychiatric disorders: a nationwide cohort and genome-wide Mendelian randomization study | 5.5 | 7 | Citations (PDF) |
| 53 | Effects of ACLY Inhibition on Body Weight Distribution: A Drug Target Mendelian Randomization Study | 2.5 | 2 | Citations (PDF) |
| 54 | Addressing the credibility crisis in Mendelian randomization | 7.1 | 85 | Citations (PDF) |
| 55 | Quantifying Triglyceride-Rich Lipoprotein Atherogenicity, Associations With Inflammation, and Implications for Risk Assessment Using Non-HDL Cholesterol | 2.3 | 58 | Citations (PDF) |
| 56 | Genetic analyses of birthweight and cardiovascular disease | 2.2 | 0 | Citations (PDF) |
| 57 | Common pitfalls in drug target Mendelian randomization and how to avoid them | 7.1 | 44 | Citations (PDF) |
| 58 | Illustrating the structures of bias from immortal time using directed acyclic graphs | 4.9 | 10 | Citations (PDF) |
| 59 | Reassessing the causal role of obesity in breast cancer susceptibility: a comprehensive multivariable Mendelian randomization investigating the distribution and timing of exposure | 4.9 | 27 | Citations (PDF) |
| 60 | Statistical methods for cis‐Mendelian randomization with two‐sample summary‐level data | 3.1 | 139 | Citations (PDF) |
| 61 | Educational attainment, structural brain reserve and Alzheimer’s disease: a Mendelian randomization analysisBrain, 2023, 146, 2059-2074 | 8.4 | 117 | Citations (PDF) |
| 62 | Linear and Nonlinear Associations Between Vitamin D and Grip Strength: A Mendelian Randomization Study in UK Biobank | 3.4 | 8 | Citations (PDF) |
| 63 | Relationship Between Ascending Thoracic Aortic Diameter and Blood Pressure: A Mendelian Randomization Study | 6.0 | 17 | Citations (PDF) |
| 64 | An empirical investigation into the impact of winner’s curse on estimates from Mendelian randomization | 4.9 | 67 | Citations (PDF) |
| 65 | Estimation of time-varying causal effects with multivariable Mendelian randomization: some cautionary notes | 4.9 | 20 | Citations (PDF) |
| 66 | Using genetic association data to guide drug discovery and development: Review of methods and applications | 6.5 | 151 | Citations (PDF) |
| 67 | Sex‐Specific Reproductive Factors Augment Cardiovascular Disease Risk in Women: A Mendelian Randomization Study | 4.0 | 51 | Citations (PDF) |
| 68 | Physical Activity, Sedentary Behavior, and Type 2 Diabetes: Mendelian Randomization Analysis | 0.3 | 36 | Citations (PDF) |
| 69 | Association of gout with brain reserve and vulnerability to neurodegenerative disease | 13.7 | 22 | Citations (PDF) |
| 70 | Genome-wide association study of thoracic aortic aneurysm and dissection in the Million Veteran Program | 25.2 | 65 | Citations (PDF) |
| 71 | Triglyceride-rich lipoprotein remnants, low-density lipoproteins, and risk of coronary heart disease: a UK Biobank study | 2.2 | 168 | Citations (PDF) |
| 72 | Relaxing parametric assumptions for non-linear Mendelian randomization using a doubly-ranked stratification method | 3.2 | 85 | Citations (PDF) |
| 73 | Associations between vitamin D and autoimmune diseases: Mendelian randomization analysis | 3.8 | 27 | Citations (PDF) |
| 74 | Multi-response Mendelian randomization: Identification of shared and distinct exposures for multimorbidity and multiple related disease outcomes | 6.5 | 26 | Citations (PDF) |
| 75 | Appraising the causal relationship between plasma caffeine levels and neuropsychiatric disorders through Mendelian randomization | 7.1 | 19 | Citations (PDF) |
| 76 | Genetically Predicted Vegetable Intake and Cardiovascular Diseases and Risk Factors: An Investigation with Mendelian Randomization | 4.4 | 9 | Citations (PDF) |
| 77 | Efficacy of metformin targets on cardiometabolic health in the general population and non-diabetic individuals: a Mendelian randomization study | 9.7 | 30 | Citations (PDF) |
| 78 | A genome-wide association study of blood cell morphology identifies cellular proteins implicated in disease aetiology | 13.7 | 34 | Citations (PDF) |
| 79 | Genome-wide association meta-analysis identifies risk loci for abdominal aortic aneurysm and highlights PCSK9 as a therapeutic target | 25.2 | 91 | Citations (PDF) |
| 80 | Genetic insights into resting heart rate and its role in cardiovascular disease | 13.7 | 33 | Citations (PDF) |
| 81 | Using genetics to examine the overall and sex-specific associations of branch-chain amino acids and the valine metabolite, 3-hydroxyisobutyrate, with ischemic heart disease and diabetes: A two-sample Mendelian randomization study | 1.5 | 6 | Citations (PDF) |
| 82 | Age at Menopause and the Risk of Stroke: Observational and Mendelian Randomization Analysis in 204 244 Postmenopausal Women | 4.0 | 11 | Citations (PDF) |
| 83 | Height, Autoimmune Thyroid Disease, and Thyroid Cancer: A Mendelian Randomization Study | 4.4 | 13 | Citations (PDF) |
| 84 | Genome-Wide Association and Two-Sample Mendelian Randomization Analyses of Plasma Ghrelin and Gastrointestinal Cancer Risk | 1.1 | 4 | Citations (PDF) |
| 85 | TIE1 and TEK signalling, intraocular pressure, and primary open-angle glaucoma: a Mendelian randomization study | 6.4 | 11 | Citations (PDF) |
| 86 | Selection of genetic instruments in Mendelian randomisation studies of sleep traits | 1.6 | 15 | Citations (PDF) |
| 87 | Mendelian randomization for cardiovascular diseases: principles and applications | 2.2 | 682 | Citations (PDF) |
| 88 | The citrate transporter SLC13A5 as a therapeutic target for kidney disease: evidence from Mendelian randomization to inform drug development | 7.1 | 10 | Citations (PDF) |
| 89 | Uncovering associations between pre-existing conditions and COVID-19 Severity: A polygenic risk score approach across three large biobanks | 3.2 | 9 | Citations (PDF) |
| 90 | An efficient and robust approach to Mendelian randomization with measured pleiotropic effects in a high-dimensional setting | 2.1 | 8 | Citations (PDF) |
| 91 | Reciprocal interaction between depression and pain: results from a comprehensive bidirectional Mendelian randomization study and functional annotation analysis | 4.2 | 59 | Citations (PDF) |
| 92 | Genetically predicted circulating vitamin C in relation to cardiovascular disease | 2.0 | 12 | Citations (PDF) |
| 93 | Serum Estradiol and 20 Site-Specific Cancers in Women: Mendelian Randomization Study | 4.0 | 30 | Citations (PDF) |
| 94 | Obesity and Kidney Function: A Two-Sample Mendelian Randomization Study | 1.1 | 87 | Citations (PDF) |
| 95 | Noise-augmented directional clustering of genetic association data identifies distinct mechanisms underlying obesity | 3.2 | 18 | Citations (PDF) |
| 96 | Evidence for Shared Genetic Aetiology Between Schizophrenia, Cardiometabolic, and Inflammation-Related Traits: Genetic Correlation and Colocalization Analyses | 1.4 | 37 | Citations (PDF) |
| 97 | Additive Effects of Genetic Interleukin‐6 Signaling Downregulation and Low‐Density Lipoprotein Cholesterol Lowering on Cardiovascular Disease: A 2×2 Factorial Mendelian Randomization Analysis | 4.0 | 36 | Citations (PDF) |
| 98 | Systematic review of Mendelian randomization studies on risk of cancer | 7.1 | 80 | Citations (PDF) |
| 99 | Genetically Predicted Neutrophil-to-Lymphocyte Ratio and Coronary Artery Disease: Evidence From Mendelian Randomization | 2.9 | 9 | Citations (PDF) |
| 100 | Genetically predicted sex hormone levels and health outcomes: phenome-wide Mendelian randomization investigation | 4.9 | 52 | Citations (PDF) |
| 101 | Elucidating mechanisms of genetic cross-disease associations at the PROCR vascular disease locus | 13.7 | 19 | Citations (PDF) |
| 102 | Systemic iron status and maternal pregnancy complications: a Mendelian randomization study | 4.9 | 7 | Citations (PDF) |
| 103 | Genetically Determined Reproductive Aging and Coronary Heart Disease: A Bidirectional 2-sample Mendelian Randomization | 4.0 | 23 | Citations (PDF) |
| 104 | Lipid traits and type 2 diabetes risk in African ancestry individuals: A Mendelian Randomization study | 9.7 | 35 | Citations (PDF) |
| 105 | Genetic evidence for vitamin D and cardiovascular disease: choice of variants is critical | 2.2 | 15 | Citations (PDF) |
| 106 | Combining evidence from Mendelian randomization and colocalization: Review and comparison of approaches | 6.5 | 465 | Citations (PDF) |
| 107 | Genetically Predicted Pulse Pressure and Risk of Abdominal Aortic Aneurysm: A Mendelian Randomization Analysis | 2.9 | 3 | Citations (PDF) |
| 108 | Genetically predicted on-statin LDL response is associated with higher intracerebral haemorrhage riskBrain, 2022, 145, 2677-2686 | 8.4 | 33 | Citations (PDF) |
| 109 | Avoiding collider bias in Mendelian randomization when performing stratified analyses | 5.3 | 45 | Citations (PDF) |
| 110 | Genome-wide analyses of 200,453 individuals yield new insights into the causes and consequences of clonal hematopoiesis | 25.2 | 349 | Citations (PDF) |
| 111 | Associations between moderate alcohol consumption, brain iron, and cognition in UK Biobank participants: Observational and mendelian randomization analyses | 8.0 | 76 | Citations (PDF) |
| 112 | Appraising the causal role of smoking in multiple diseases: A systematic review and meta-analysis of Mendelian randomization studies | 9.7 | 267 | Citations (PDF) |
| 113 | Alcohol consumption and telomere length: Mendelian randomization clarifies alcohol’s effects | 7.8 | 85 | Citations (PDF) |
| 114 | Arterial Stiffness and Diabetes Risk in Framingham Heart Study and UK Biobank | 13.1 | 71 | Citations (PDF) |
| 115 | Associations of genetically predicted IL-6 signaling with cardiovascular disease risk across population subgroups | 7.1 | 59 | Citations (PDF) |
| 116 | Genetically predicted cortisol levels and risk of venous thromboembolism | 2.3 | 9 | Citations (PDF) |
| 117 | Software Application Profile: SUMnlmr, an R package that facilitates flexible and reproducible non-linear Mendelian randomization analyses | 4.9 | 17 | Citations (PDF) |
| 118 | Coffee consumption and cancer risk: a Mendelian randomisation study | 5.3 | 50 | Citations (PDF) |
| 119 | Circulating vitamin C and digestive system cancers: Mendelian randomization study | 5.3 | 28 | Citations (PDF) |
| 120 | Cross-fitted instrument: A blueprint for one-sample Mendelian randomization | 3.1 | 4 | Citations (PDF) |
| 121 | Genetic Evidence for Protective Effects of Angiotensin-Converting Enzyme Against Alzheimer Disease But Not Other Neurodegenerative Diseases in European Populations | 2.8 | 22 | Citations (PDF) |
| 122 | l-carnitine, a friend or foe for cardiovascular disease? A Mendelian randomization study | 7.1 | 34 | Citations (PDF) |
| 123 | Systematic Mendelian randomization using the human plasma proteome to discover potential therapeutic targets for stroke | 13.7 | 121 | Citations (PDF) |
| 124 | Genetically Predicted Lipid Traits, Diabetes Liability, and Carotid Intima-Media Thickness in African Ancestry Individuals: A Mendelian Randomization Study | 2.9 | 4 | Citations (PDF) |
| 125 | Rheumatoid arthritis and risk of site-specific cancers: Mendelian randomization study in European and East Asian populations | 3.9 | 21 | Citations (PDF) |
| 126 | Genetically predicted plasma phospholipid arachidonic acid concentrations and 10 site-specific cancers in UK biobank and genetic consortia participants: A mendelian randomization study | 5.3 | 28 | Citations (PDF) |
| 127 | Genetically proxied interleukin-6 receptor inhibition: opposing associations with COVID-19 and pneumonia | 8.7 | 37 | Citations (PDF) |
| 128 | MR-Clust: clustering of genetic variants in Mendelian randomization with similar causal estimates | 4.7 | 82 | Citations (PDF) |
| 129 | A cross-platform approach identifies genetic regulators of human metabolism and health | 25.2 | 197 | Citations (PDF) |
| 130 | Genetically predicted physical activity levels are associated with lower colorectal cancer risk: a Mendelian randomisation study | 5.5 | 35 | Citations (PDF) |
| 131 | Mendelian randomization for studying the effects of perturbing drug targets | 0.9 | 198 | Citations (PDF) |
| 132 | Dose–response relationship between genetically proxied average blood glucose levels and incident coronary heart disease in individuals without diabetes mellitus | 7.5 | 23 | Citations (PDF) |
| 133 | Polygenic risk scores in cardiovascular risk prediction: A cohort study and modelling analyses | 8.0 | 161 | Citations (PDF) |
| 134 | Body mass index and subfertility: multivariable regression and Mendelian randomization analyses in the Norwegian Mother, Father and Child Cohort Study | 1.0 | 46 | Citations (PDF) |
| 135 | Thyroid function, sex hormones and sexual function: a Mendelian randomization study | 5.3 | 97 | Citations (PDF) |
| 136 | A fast and efficient colocalization algorithm for identifying shared genetic risk factors across multiple traits | 13.7 | 522 | Citations (PDF) |
| 137 | Mendelian randomization for studying the effects of perturbing drug targets | 0.9 | 81 | Citations (PDF) |
| 138 | Genetic liability to insomnia in relation to cardiovascular diseases: a Mendelian randomisation study | 5.3 | 63 | Citations (PDF) |
| 139 | The potential shared role of inflammation in insulin resistance and schizophrenia: A bidirectional two-sample mendelian randomization study | 8.0 | 74 | Citations (PDF) |
| 140 | Homocysteine, B vitamins, and cardiovascular disease: a Mendelian randomization study | 7.1 | 138 | Citations (PDF) |
| 141 | Actionable druggable genome-wide Mendelian randomization identifies repurposing opportunities for COVID-19 | 33.0 | 213 | Citations (PDF) |
| 142 | Genetically predicted circulating B vitamins in relation to digestive system cancers | 5.5 | 15 | Citations (PDF) |
| 143 | Plasma Cortisol and Risk of Atrial Fibrillation: A Mendelian Randomization Study | 4.0 | 23 | Citations (PDF) |
| 144 | Genetically Proxied Inhibition of Coagulation Factors and Risk of Cardiovascular Disease: A Mendelian Randomization Study | 4.0 | 24 | Citations (PDF) |
| 145 | Risk factors mediating the effect of body mass index and waist-to-hip ratio on cardiovascular outcomes: Mendelian randomization analysis | 3.0 | 68 | Citations (PDF) |
| 146 | Coffee Consumption and Cardiovascular Diseases: A Mendelian Randomization Study | 4.4 | 38 | Citations (PDF) |
| 147 | Association of inflammation with depression and anxiety: evidence for symptom-specificity and potential causality from UK Biobank and NESDA cohorts | 7.8 | 314 | Citations (PDF) |
| 148 | The causal effects of serum lipids and apolipoproteins on kidney function: multivariable and bidirectional Mendelian-randomization analyses | 4.9 | 29 | Citations (PDF) |
| 149 | Genetic Evidence for Repurposing of GLP1R (Glucagon‐Like Peptide‐1 Receptor) Agonists to Prevent Heart Failure | 4.0 | 34 | Citations (PDF) |
| 150 | Body size and composition and risk of site-specific cancers in the UK Biobank and large international consortia: A mendelian randomisation study | 8.0 | 73 | Citations (PDF) |
| 151 | Assessing the role of cortisol in cancer: a wide-ranged Mendelian randomisation study | 5.5 | 35 | Citations (PDF) |
| 152 | Role of inflammation in depression and anxiety: Tests for disorder specificity, linearity and potential causality of association in the UK Biobank | 8.2 | 82 | Citations (PDF) |
| 153 | GWAS Identifies LINC01184/SLC12A2 as a Risk Locus for Skin and Soft Tissue Infections | 2.3 | 8 | Citations (PDF) |
| 154 | Estimating the Population Benefits of Blood Pressure Lowering: A Wide‐Angled Mendelian Randomization Study in UK Biobank | 4.0 | 22 | Citations (PDF) |
| 155 | Associations of immunological proteins/traits with schizophrenia, major depression and bipolar disorder: A bi-directional two-sample mendelian randomization study | 4.5 | 188 | Citations (PDF) |
| 156 | High-throughput multivariable Mendelian randomization analysis prioritizes apolipoprotein B as key lipid risk factor for coronary artery disease | 4.9 | 75 | Citations (PDF) |
| 157 | Genetically Predicted Type 2 Diabetes Mellitus Liability, Glycated Hemoglobin and Cardiovascular Diseases: A Wide-Angled Mendelian Randomization Study | 2.5 | 20 | Citations (PDF) |
| 158 | Integrative analysis of the plasma proteome and polygenic risk of cardiometabolic diseases | 17.1 | 79 | Citations (PDF) |
| 159 | Association of Smoking, Alcohol Consumption, Blood Pressure, Body Mass Index, and Glycemic Risk Factors With Age-Related Macular Degeneration | 6.1 | 91 | Citations (PDF) |
| 160 | Discordant associations of educational attainment with ASD and ADHD implicate a polygenic form of pleiotropy | 13.7 | 14 | Citations (PDF) |
| 161 | Leveraging Genetic Data to Elucidate the Relationship Between COVID‐19 and Ischemic Stroke | 4.0 | 17 | Citations (PDF) |
| 162 | Causal role of high body mass index in multiple chronic diseases: a systematic review and meta-analysis of Mendelian randomization studies | 7.1 | 238 | Citations (PDF) |
| 163 | Circulating phylloquinone, inactive Matrix Gla protein and coronary heart disease risk: A two-sample Mendelian Randomization study | 5.3 | 20 | Citations (PDF) |
| 164 | Body mass index and body composition in relation to 14 cardiovascular conditions in UK Biobank: a Mendelian randomization study | 2.2 | 402 | Citations (PDF) |
| 165 | A Bayesian approach to Mendelian randomization with multiple pleiotropic variants | 2.1 | 44 | Citations (PDF) |
| 166 | Factorial Mendelian randomization: using genetic variants to assess interactions | 4.9 | 87 | Citations (PDF) |
| 167 | Selecting likely causal risk factors from high-throughput experiments using multivariable Mendelian randomization | 13.7 | 231 | Citations (PDF) |
| 168 | Impact of Genetically Predicted Red Blood Cell Traits on Venous Thromboembolism: Multivariable Mendelian Randomization Study Using UK Biobank | 4.0 | 30 | Citations (PDF) |
| 169 | Genetically proxied milk consumption and risk of colorectal, bladder, breast, and prostate cancer: a two-sample Mendelian randomization study | 7.1 | 34 | Citations (PDF) |
| 170 | Smoking, alcohol consumption, and cancer: A mendelian randomisation study in UK Biobank and international genetic consortia participants | 8.0 | 167 | Citations (PDF) |
| 171 | Effects of tumour necrosis factor on cardiovascular disease and cancer: A two-sample Mendelian randomization study | 9.7 | 120 | Citations (PDF) |
| 172 | Association of Prior Atherosclerotic Cardiovascular Disease with Dementia After Stroke: A Retrospective Cohort Study | 2.6 | 7 | Citations (PDF) |
| 173 | Genetically raised serum bilirubin levels and lung cancer: a cohort study and Mendelian randomisation using UK Biobank | 5.6 | 50 | Citations (PDF) |
| 174 | Polygenic modelling of treatment effect heterogeneity | 3.1 | 7 | Citations (PDF) |
| 175 | Alcohol Consumption and Cardiovascular Disease | 2.9 | 167 | Citations (PDF) |
| 176 | Lipoprotein(a) in Alzheimer, Atherosclerotic, Cerebrovascular, Thrombotic, and Valvular Disease | 18.0 | 101 | Citations (PDF) |
| 177 | IGF-1 and cardiometabolic diseases: a Mendelian randomisation study | 7.5 | 70 | Citations (PDF) |
| 178 | Circulating interleukins in relation to coronary artery disease, atrial fibrillation and ischemic stroke and its subtypes: A two-sample Mendelian randomization study | 2.2 | 54 | Citations (PDF) |
| 179 | Genetically Predicted Midlife Blood Pressure and Coronary Artery Disease Risk: Mendelian Randomization Analysis | 4.0 | 27 | Citations (PDF) |
| 180 | Iron Status and Cancer Risk in UK Biobank: A Two-Sample Mendelian Randomization Study | 4.4 | 29 | Citations (PDF) |
| 181 | Using human genetics to understand the disease impacts of testosterone in men and women | 33.0 | 663 | Citations (PDF) |
| 182 | A robust and efficient method for Mendelian randomization with hundreds of genetic variants | 13.7 | 616 | Citations (PDF) |
| 183 | A comparison of robust Mendelian randomization methods using summary data | 3.1 | 633 | Citations (PDF) |
| 184 | Genetic predisposition to smoking in relation to 14 cardiovascular diseases | 2.2 | 144 | Citations (PDF) |
| 185 | ACE inhibition and cardiometabolic risk factors, lung
ACE2
and
TMPRSS2
gene expression, and plasma ACE2 levels: a Mendelian randomization study | 2.4 | 16 | Citations (PDF) |
| 186 | Use of a Genetic Variant Related to Circulating FXa (Activated Factor X) Levels to Proxy the Effect of FXa Inhibition on Cardiovascular Outcomes | 2.9 | 9 | Citations (PDF) |
| 187 | Urinary Albumin, Sodium, and Potassium and Cardiovascular Outcomes in the UK Biobank | 6.6 | 46 | Citations (PDF) |
| 188 | Guidelines for performing Mendelian randomization investigations | 0.9 | 616 | Citations (PDF) |
| 189 | MendelianRandomization v0.5.0: updates to an R package for performing Mendelian randomization analyses using summarized data | 0.9 | 141 | Citations (PDF) |
| 190 | Body mass index and risk of dying from a bloodstream infection: A Mendelian randomization study | 8.0 | 26 | Citations (PDF) |
| 191 | MendelianRandomization v0.5.0: updates to an R package for performing Mendelian randomization analyses using summarized data | 0.9 | 29 | Citations (PDF) |
| 192 | How humans can contribute to Mendelian randomization analyses | 4.9 | 24 | Citations (PDF) |
| 193 | Body composition and atrial fibrillation: a Mendelian randomization study | 2.2 | 54 | Citations (PDF) |
| 194 | Robust methods in Mendelian randomization via penalization of heterogeneous causal estimates | 2.3 | 169 | Citations (PDF) |
| 195 | Disentangling polygenic associations between attention-deficit/hyperactivity disorder, educational attainment, literacy and language | 5.2 | 31 | Citations (PDF) |
| 196 | Serum magnesium and calcium levels in relation to ischemic stroke | 1.0 | 55 | Citations (PDF) |
| 197 | Do Cerebral Small Vessel Disease and Multiple Sclerosis Share Common Mechanisms of White Matter Injury? | 5.9 | 22 | Citations (PDF) |
| 198 | PhenoScanner V2: an expanded tool for searching human genotype–phenotype associations | 4.7 | 1,927 | Citations (PDF) |
| 199 | Resting Heart Rate and Cardiovascular Disease | 2.9 | 21 | Citations (PDF) |
| 200 | Assessing the causal association of glycine with risk of cardio-metabolic diseases | 13.7 | 132 | Citations (PDF) |
| 201 | Thyroid Function and Dysfunction in Relation to 16 Cardiovascular Diseases | 2.9 | 53 | Citations (PDF) |
| 202 | Body mass index and the association between low-density lipoprotein cholesterol as predicted by HMGCR genetic variants and breast cancer risk | 4.9 | 5 | Citations (PDF) |
| 203 | Association of menopausal characteristics and risk of coronary heart disease: a pan-European case–cohort analysis | 4.9 | 83 | Citations (PDF) |
| 204 | Plasma Phospholipid Fatty Acids, FADS1 and Risk of 15 Cardiovascular Diseases: A Mendelian Randomisation Study | 4.4 | 65 | Citations (PDF) |
| 205 | Mendelian randomization in the bone field | 3.4 | 46 | Citations (PDF) |
| 206 | Contextualizing selection bias in Mendelian randomization: how bad is it likely to be? | 4.9 | 182 | Citations (PDF) |
| 207 | Shared mechanisms between coronary heart disease and depression: findings from a large UK general population-based cohort | 7.8 | 262 | Citations (PDF) |
| 208 | Guidelines for performing Mendelian randomization investigations | 0.9 | 1,431 | Citations (PDF) |
| 209 | Genetically elevated gamma-glutamyltransferase and Alzheimer's disease | 3.7 | 6 | Citations (PDF) |
| 210 | Inferring Causal Relationships Between Risk Factors and Outcomes from Genome-Wide Association Study Data | 6.6 | 277 | Citations (PDF) |
| 211 | Association between a functional interleukin 6 receptor genetic variant and risk of depression and psychosis in a population-based birth cohort | 4.5 | 117 | Citations (PDF) |
| 212 | Birthweight, Type 2 Diabetes Mellitus, and Cardiovascular Disease | 2.9 | 110 | Citations (PDF) |
| 213 | Genetic predictors of testosterone and their associations with cardiovascular disease and risk factors: A Mendelian randomization investigation | 2.2 | 55 | Citations (PDF) |
| 214 | Modal-based estimation via heterogeneity-penalized weighting: model averaging for consistent and efficient estimation in Mendelian randomization when a plurality of candidate instruments are valid | 4.9 | 82 | Citations (PDF) |
| 215 | Mendelian randomization with a binary exposure variable: interpretation and presentation of causal estimates | 5.3 | 511 | Citations (PDF) |
| 216 | Serum magnesium levels and risk of coronary artery disease: Mendelian randomisation study | 7.1 | 53 | Citations (PDF) |
| 217 | Serum 25-hydroxyvitamin D levels and risk of lung cancer and histologic types: a Mendelian randomisation analysis of the HUNT study | 8.7 | 14 | Citations (PDF) |
| 218 | Genetic association between adiposity and gout: a Mendelian randomization study | 1.9 | 83 | Citations (PDF) |
| 219 | A review of instrumental variable estimators for Mendelian randomization | 1.6 | 1,648 | Citations (PDF) |
| 220 | Estimating and contextualizing the attenuation of odds ratios due to non collapsibility | 1.3 | 21 | Citations (PDF) |
| 221 | Investigating causality in associations between smoking initiation and schizophrenia using Mendelian randomization | 3.4 | 57 | Citations (PDF) |
| 222 | Associations of triglyceride levels with longevity and frailty: A Mendelian randomization analysis | 3.4 | 18 | Citations (PDF) |
| 223 | MendelianRandomization: an R package for performing Mendelian randomization analyses using summarized data | 4.9 | 1,951 | Citations (PDF) |
| 224 | Mendelian Randomization Implicates High-Density Lipoprotein Cholesterol–Associated Mechanisms in Etiology of Age-Related Macular Degeneration | 7.9 | 148 | Citations (PDF) |
| 225 | Sensitivity Analyses for Robust Causal Inference from Mendelian Randomization Analyses with Multiple Genetic Variants | 2.8 | 1,769 | Citations (PDF) |
| 226 | Interpreting findings from Mendelian randomization using the MR-Egger method | 5.3 | 4,169 | Citations (PDF) |
| 227 | Power calculator for instrumental variable analysis in pharmacoepidemiology | 4.9 | 15 | Citations (PDF) |
| 228 | Causal Effect of Plasminogen Activator Inhibitor Type 1 on Coronary Heart Disease | 4.0 | 111 | Citations (PDF) |
| 229 | Semiparametric methods for estimation of a nonlinear exposure‐outcome relationship using instrumental variables with application to Mendelian randomization | 3.1 | 278 | Citations (PDF) |
| 230 | Genetically-Predicted Adult Height and Alzheimer’s Disease | 2.6 | 14 | Citations (PDF) |
| 231 | Extending the MR‐Egger method for multivariable Mendelian randomization to correct for both measured and unmeasured pleiotropy | 1.7 | 411 | Citations (PDF) |
| 232 | Mendelian randomization with fine‐mapped genetic data: Choosing from large numbers of correlated instrumental variables | 3.1 | 216 | Citations (PDF) |
| 233 | Dissecting Causal Pathways Using Mendelian Randomization with Summarized Genetic Data: Application to Age at Menarche and Risk of Breast Cancer | 4.2 | 212 | Citations (PDF) |
| 234 | Association of Genetic Variants Related to Serum Calcium Levels With Coronary Artery Disease and Myocardial Infarction | 16.5 | 215 | Citations (PDF) |
| 235 | Circulating Total Bilirubin and Future Risk of Hypertension in the General Population: The Prevention of Renal and Vascular End‐Stage Disease (PREVEND) Prospective Study and a Mendelian Randomization Approach | 4.0 | 34 | Citations (PDF) |
| 236 | Response to Hartwig and Davies | 4.9 | 164 | Citations (PDF) |
| 237 | Bias due to participant overlap in two‐sample Mendelian randomization | 3.1 | 1,563 | Citations (PDF) |
| 238 | Combining information on multiple instrumental variables in Mendelian randomization: comparison of allele score and summarized data methods | 1.7 | 1,078 | Citations (PDF) |
| 239 | Natriuretic peptides and integrated risk assessment for cardiovascular disease: an individual-participant-data meta-analysis | 21.7 | 203 | Citations (PDF) |
| 240 | Association Between Low-Density Lipoprotein Cholesterol–Lowering Genetic Variants and Risk of Type 2 Diabetes | 16.5 | 375 | Citations (PDF) |
| 241 | Consistent Estimation in Mendelian Randomization with Some Invalid Instruments Using a Weighted Median Estimator | 3.1 | 8,334 | Citations (PDF) |
| 242 | Serum gamma-glutamyl transferase and risk of type 2 diabetes in the general Korean population: a Mendelian randomization study | 2.9 | 28 | Citations (PDF) |
| 243 | Moderate alcohol drinking in pregnancy increases risk for children's persistent conduct problems: causal effects in a Mendelian randomisation study | 6.3 | 50 | Citations (PDF) |
| 244 | Investigating causality in the association between 25(OH)D and schizophrenia | 3.4 | 49 | Citations (PDF) |
| 245 | Trans-ancestry meta-analyses identify rare and common variants associated with blood pressure and hypertension | 25.2 | 302 | Citations (PDF) |
| 246 | BMI as a Modifiable Risk Factor for Type 2 Diabetes: Refining and Understanding Causal Estimates Using Mendelian Randomization | 4.2 | 187 | Citations (PDF) |
| 247 | Identification of genomic loci associated with resting heart rate and shared genetic predictors with all-cause mortality | 25.2 | 159 | Citations (PDF) |
| 248 | Predicting the Direction of Causal Effect Based on an Instrumental Variable Analysis: A Cautionary Tale | 1.2 | 15 | Citations (PDF) |
| 249 | Methods for meta-analysis of individual participant data from Mendelian randomisation studies with binary outcomes | 1.6 | 12 | Citations (PDF) |
| 250 | Mendelian randomization to assess causal effects of blood lipids on coronary heart disease | 2.2 | 65 | Citations (PDF) |
| 251 | Best (but oft-forgotten) practices: the design, analysis, and interpretation of Mendelian randomization studies | 4.7 | 617 | Citations (PDF) |
| 252 | Beyond Mendelian randomization: how to interpret evidence of shared genetic predictors | 3.7 | 93 | Citations (PDF) |
| 253 | Genetic Predisposition to an Impaired Metabolism of the Branched-Chain Amino Acids and Risk of Type 2 Diabetes: A Mendelian Randomisation Analysis | 8.0 | 404 | Citations (PDF) |
| 254 | The many weak instruments problem and Mendelian randomization | 1.7 | 142 | Citations (PDF) |
| 255 | Commentary | 2.8 | 8 | Citations (PDF) |
| 256 | Multivariable Mendelian Randomization: The Use of Pleiotropic Genetic Variants to Estimate Causal Effects | 3.3 | 1,528 | Citations (PDF) |
| 257 | Mendelian randomization: where are we now and where are we going? | 4.9 | 247 | Citations (PDF) |
| 258 | Mendelian randomization with invalid instruments: effect estimation and bias detection through Egger regression | 4.9 | 9,265 | Citations (PDF) |
| 259 | Association between circulating 25-hydroxyvitamin D and incident type 2 diabetes: a mendelian randomisation study | 21.7 | 179 | Citations (PDF) |
| 260 | Re: “Multivariable Mendelian Randomization: The Use of Pleiotropic Genetic Variants to Estimate Causal Effects” | 3.3 | 431 | Citations (PDF) |
| 261 | Genetic determinants of telomere length and risk of common cancers: a Mendelian randomization study | 2.9 | 144 | Citations (PDF) |
| 262 | Association of Cardiometabolic Multimorbidity With Mortality | 16.5 | 991 | Citations (PDF) |
| 263 | Using published data in Mendelian randomization: a blueprint for efficient identification of causal risk factors | 5.3 | 1,694 | Citations (PDF) |
| 264 | Genetically Determined Height and Coronary Artery Disease | 34.5 | 249 | Citations (PDF) |
| 265 | Iron and hepcidin as risk factors in atherosclerosis: what do the genes say? | 2.8 | 30 | Citations (PDF) |
| 266 | Network Mendelian randomization: using genetic variants as instrumental variables to investigate mediation in causal pathways | 4.9 | 524 | Citations (PDF) |
| 267 | Sample size and power calculations in Mendelian randomization with a single instrumental variable and a binary outcome | 4.9 | 584 | Citations (PDF) |
| 268 | Lack of Identification in Semiparametric Instrumental Variable Models With Binary Outcomes | 3.3 | 19 | Citations (PDF) |
| 269 | Instrumental Variable Analysis with a Nonlinear Exposure–Outcome Relationship | 2.8 | 206 | Citations (PDF) |
| 270 | Using Multivariable Mendelian Randomization to Disentangle the Causal Effects of Lipid Fractions | 2.3 | 94 | Citations (PDF) |
| 271 | Mendelian Randomization Analysis With Multiple Genetic Variants Using Summarized Data | 3.1 | 5,682 | Citations (PDF) |
| 272 | Identifying the odds ratio estimated by a two‐stage instrumental variable analysis with a logistic regression model | 1.7 | 73 | Citations (PDF) |
| 273 | Using Mendelian randomization to assess and develop clinical interventions: limitations and benefits | 2.3 | 15 | Citations (PDF) |
| 274 | Use of allele scores as instrumental variables for Mendelian randomization | 4.9 | 442 | Citations (PDF) |
| 275 | Efficient Design for Mendelian Randomization Studies: Subsample and 2-Sample Instrumental Variable Estimators | 3.3 | 1,315 | Citations (PDF) |
| 276 | Combining multiple imputation and meta‐analysis with individual participant data | 1.7 | 89 | Citations (PDF) |
| 277 | Vitamin D and high blood pressure: causal association or epiphenomenon? | 5.3 | 126 | Citations (PDF) |
| 278 | Re: "Credible Mendelian Randomization Studies: Approaches For Evaluating The Instrumental Variable Assumptions" | 3.3 | 9 | Citations (PDF) |
| 279 | Use of Mendelian randomisation to assess potential benefit of clinical intervention | 0.2 | 290 | Citations (PDF) |
| 280 | Improving bias and coverage in instrumental variable analysis with weak instruments for continuous and binary outcomes | 1.7 | 83 | Citations (PDF) |
| 281 | Bias in causal estimates from Mendelian randomization studies with weak instruments | 1.7 | 391 | Citations (PDF) |
| 282 | Avoiding bias from weak instruments in Mendelian randomization studies | 4.9 | 3,638 | Citations (PDF) |
| 283 | Missing Data Methods in Mendelian Randomization Studies With Multiple Instruments | 3.3 | 17 | Citations (PDF) |
| 284 | Bayesian methods for meta‐analysis of causal relationships estimated using genetic instrumental variables | 1.7 | 22 | Citations (PDF) |
| 285 | Band engineering at the GaAsAlGaAs heterojunction using ultra-thin Si and Be dipole layers: a comparison of modification techniques | 6.6 | 2 | Citations (PDF) |
| 286 | Selection of materials to reduce environmental impact: a case study on refrigerator insulation | 4.7 | 39 | Citations (PDF) |
| 287 | Modifiable pathways in Alzheimer’s disease: Mendelian randomisation analysis | 0.1 | 340 | Citations (PDF) |
| 288 | The MR-Base platform supports systematic causal inference across the human phenome | 0.7 | 7,383 | Citations (PDF) |
| 289 | Association of genetically predicted testosterone with thromboembolism, heart failure, and myocardial infarction: mendelian randomisation study in UK Biobank | 0.1 | 109 | Citations (PDF) |
| 290 | Body mass index and all cause mortality in HUNT and UK Biobank studies: linear and non-linear mendelian randomisation analyses | 0.2 | 170 | Citations (PDF) |
| 291 | Predicting the effect of statins on cancer risk using genetic variants from a Mendelian randomization study in the UK Biobank | 0.7 | 37 | Citations (PDF) |
| 292 | Title is missing! 0 | | 1 | Citations (PDF) |
| 293 | MendelianRandomization v0.9.0: updates to an R package for performing Mendelian randomization analyses using summarized data | 0.9 | 20 | Citations (PDF) |
| 294 | MendelianRandomization v0.9.0: updates to an R package for performing Mendelian randomization analyses using summarized data | 0.9 | 61 | Citations (PDF) |
| 295 | A drug target for erectile dysfunction to help improve fertility, sexual activity, and wellbeing: mendelian randomisation study | 0.2 | 31 | Citations (PDF) |
| 296 | Remnant cholesterol concentrations best explain the cardiovascular benefit of APOC3 genetic inhibition: A drug target Mendelian Randomization study | 2.5 | 4 | Citations (PDF) |
| 297 | Reassessing the association between age at menarche and cardiovascular disease: observational and Mendelian randomization analyses | 2.0 | 2 | Citations (PDF) |
| 298 | Periodontitis and Systemic Disease: The Impact of Covariate Selection | 5.5 | 7 | Citations (PDF) |
| 299 | A cautionary note on the naive use of general-population biobanks to study pulmonary arterial hypertension, with a focus on Mendelian randomisation | 8.7 | 0 | Citations (PDF) |
| 300 | Alcohol use and risk of dementia in diverse populations: evidence from cohort, case–control and Mendelian randomisation approaches | 3.2 | 19 | Citations (PDF) |
| 301 | Stratification-based instrumental variable analysis framework for nonlinear effect analysis | 2.1 | 3 | Citations (PDF) |
| 302 | Alcohol consumption and risk of cancer: a Mendelian randomization analysis of four biobanks and consortium data | 7.1 | 3 | Citations (PDF) |
| 303 | Human genetics suggests differing causal pathways from HMGCR inhibition to coronary artery disease and type 2 diabetes | 4.9 | 1 | Citations (PDF) |
| 304 | Variant selection to maximize variance explained in cis-Mendelian randomization | 1.6 | 1 | Citations (PDF) |
| 305 | Extending the Use of Mendelian Randomisation With Non‐Inherited Variants to Assess Socially Transmitted Parental Exposures Under Assortative Mating | 3.1 | 0 | Citations (PDF) |
| 306 | Genetically Predicted Levels of Lipoprotein(a) and Risk of Cerebrovascular Disease | 4.0 | 2 | Citations (PDF) |
| 307 | Genetic Association of Circulating Proteins and Gene Transcripts With Spontaneous Coronary Artery Dissection | 2.9 | 2 | Citations (PDF) |
| 308 | Phenome-wide study on alcohol consumption provides genetic evidence for a causal association with multiple diseases and biomarkers | 3.2 | 0 | Citations (PDF) |
| 309 | Assessing the causal effects of environmental tobacco smoke exposure: a meta-analytic Mendelian randomization study | 2.3 | 0 | Citations (PDF) |
| 310 | PCSK9 and Breast Cancer Survival: A Mendelian Randomization Study | 1.1 | 0 | Citations (PDF) |
| 311 | Genetically proxied IL-6 signaling inhibition, lipoprotein(a) levels, and atherosclerotic disease risk | 1.5 | 0 | Citations (PDF) |
| 312 | Integrating genetic data with biological insight: A practical guide to cis-Mendelian randomization | 6.5 | 2 | Citations (PDF) |
| 313 | The Authors Respond | 2.8 | 0 | Citations (PDF) |
| 314 | No genetic evidence for an association of apolipoprotein A-I with cardiovascular outcomes at different LDL cholesterol levels: drug-target Mendelian randomization analyses | 1.5 | 0 | Citations (PDF) |
